Biblio

Export 1335 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
Journal Article
H. - D. Tang, Zhou, Y., Gao, X., Liang, L., Hou, M. - M., Qiao, Y., Ma, J. - F., and Di Chen, S. -, “Prevalence and Risk Factor of Cognitive Impairment were Different between Urban and Rural Population: A Community-Based Study.”, J Alzheimers Dis, vol. 49, no. 4, pp. 917-25, 2016.
J. René Thyrian, Hertel, J., Schulze, L. N., Dörr, M., Prüss, H., Hempel, P., Bimmler, M., Kunze, R., Grabe, H. Jörgen, Teipel, S., and Hoffmann, W., “Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1091-1097, 2018.
G. T. Grossberg, Tong, G., Burke, A. D., and Tariot, P. N., “Present Algorithms and Future Treatments for Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 4, pp. 1157-1171, 2019.
B. N. Dugger, Whiteside, C. M., Maarouf, C. L., Walker, D. G., Beach, T. G., Sue, L. I., Garcia, A., Dunckley, T., Meechoovet, B., Reiman, E. M., and Roher, A. E., “The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 345-56, 2016.
S. Zygouris, Ntovas, K., Giakoumis, D., Votis, K., Doumpoulakis, S., Segkouli, S., Karagiannidis, C., Tzovaras, D., and Tsolaki, M., “A Preliminary Study on the Feasibility of Using a Virtual Reality Cognitive Training Application for Remote Detection of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 2, pp. 619-627, 2017.
R. A. Stern, Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., Zhang, J., Gercel-Taylor, C., and Taylor, D. D., “Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
M. Gallucci, Spagnolo, P., Aricò, M., and Grossi, E., “Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.”, J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
M. Gallucci, Spagnolo, P., Aricò, M., and Grossi, E., “Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.”, J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
A. Sinai, Mokrysz, C., Bernal, J., Bohnen, I., Bonell, S., Courtenay, K., Dodd, K., Gazizova, D., Hassiotis, A., Hillier, R., McBrien, J., McCarthy, J., Mukherji, K., Naeem, A., Perez-Achiaga, N., Rantell, K., Sharma, V., Thomas, D., Walker, Z., Whitham, S., and Strydom, A., “Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 2, pp. 717-728, 2018.
S. Lima, Gago, M., Garrett, C., and M Pereira, G., “Predictors and Moderators of Quality of Life in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1113-1121, 2016.
S. Lima, Gago, M., Garrett, C., and M Pereira, G., “Predictors and Moderators of Quality of Life in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1113-1121, 2016.
L. Xu, Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., and Yao, L., “Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1045-56, 2016.
J. Zhou, Gennatas, E. D., Kramer, J. H., Miller, B. L., and Seeley, W. W., “Predicting regional neurodegeneration from the healthy brain functional connectome.”, Neuron, vol. 73, no. 6, pp. 1216-27, 2012.
M. Marizzoni, Ferrari, C., Jovicich, J., Albani, D., Babiloni, C., Cavaliere, L., Didic, M., Forloni, G., Galluzzi, S., Hoffmann, K. - T., Molinuevo, J. Luis, Nobili, F., Parnetti, L., Payoux, P., Ribaldi, F., Rossini, P. Maria, Schönknecht, P., Soricelli, A., Hensch, T., Tsolaki, M., Visser, P. Jelle, Wiltfang, J., Richardson, J. C., Bordet, R., Blin, O., and Frisoni, G. B., “Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.”, J Alzheimers Dis, 2018.
S. E. O'Bryant, Zhang, F., Johnson, L. A., Hall, J., Edwards, M., Grammas, P., Oh, E., Lyketsos, C. G., and Rissman, R. A., “A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 97-104, 2018.
K. Toups, Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Jarrett, M., and Bredesen, D. E., “Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
D. E. Bredesen, Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Kurakin, A., and Jarrett, M., “Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.”, J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.
A. J. Cross, George, J., Woodward, M. C., Ames, D., Brodaty, H., Wolfe, R., Connors, M. H., and Elliott, R. A., “Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.”, J Alzheimers Dis, vol. 60, no. 2, pp. 349-358, 2017.
T. Yamasaki, Horie, S., Ohyagi, Y., Tanaka, E., Nakamura, N., Goto, Y., Kanba, S., Kira, J. - I., and Tobimatsu, S., “A Potential VEP Biomarker for Mild Cognitive Impairment: Evidence from Selective Visual Deficit of Higher-Level Dorsal Pathway.”, J Alzheimers Dis, vol. 53, no. 2, pp. 661-76, 2016.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
E. Drummond, Goñi, F., Liu, S., Prelli, F., Scholtzova, H., and Wisniewski, T., “Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S299-S312, 2018.
D. A. Levine, Sussman, J. B., Hayward, R. A., Gałecki, A. T., Whitney, R. T., Briceño, E. M., Gross, A. L., Giordani, B. J., Elkind, M. Sv, Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., and Burke, J. F., “The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.”, J Alzheimers Dis, p. 13872877241302506, 2025.
D. A. Levine, Sussman, J. B., Hayward, R. A., Gałecki, A. T., Whitney, R. T., Briceño, E. M., Gross, A. L., Giordani, B. J., Elkind, M. Sv, Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., and Burke, J. F., “The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.”, J Alzheimers Dis, p. 13872877241302506, 2025.
D. A. Levine, Sussman, J. B., Hayward, R. A., Gałecki, A. T., Whitney, R. T., Briceño, E. M., Gross, A. L., Giordani, B. J., Elkind, M. Sv, Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., and Burke, J. F., “The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.”, J Alzheimers Dis, p. 13872877241302506, 2025.
D. A. Levine, Sussman, J. B., Hayward, R. A., Gałecki, A. T., Whitney, R. T., Briceño, E. M., Gross, A. L., Giordani, B. J., Elkind, M. Sv, Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., and Burke, J. F., “The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.”, J Alzheimers Dis, p. 13872877241302506, 2025.

Pages